Advanced Surgical Options for GLC1A

When eye drops and laser therapy (SLT) are no longer enough to reach your target pressure, or if your scans show that damage is still progressing, it may be time to consider advanced surgical options. For people with GLC1A (MYOC-associated glaucoma), the choice of surgery is often guided by the unique way this condition affects the eye’s drainage system ^[1][2].

Angle-Based Surgery (GATT)

Because the cellular dysfunction in MYOC mutations happens specifically in the trabecular meshwork (the eye’s natural drain), surgeons often start with a procedure that addresses that area directly ^[1]. One modern approach is GATT (Gonioscopy-Assisted Transluminal Trabeculotomy) ^[2].

• How it Works: Using a tiny catheter or suture, the surgeon incises the trabecular meshwork to access Schlemm’s canal, opening the eye’s natural drainage canal 360 degrees and reducing outflow resistance ^[3].
• The Benefits: GATT is “bleb-free,” meaning it doesn’t create a permanent bubble on the eye’s surface ^[2]. It can significantly lower pressure and often allows patients to stop or reduce their daily eye drops ^[1]. In a study of younger patients, GATT reduced eye pressure from nearly 30 mmHg down to about 15–17 mmHg ^[2].
• The Risks and Recovery: It is common to have a hyphema (a small amount of blood in the front of the eye) or temporary “pressure spikes” in the days after surgery ^[3][4]. These usually resolve quickly with close monitoring. GATT may be insufficient if you require a very low target pressure.

Filtering Surgery (Trabeculectomy)

If your glaucoma is advanced or if a very low target pressure is needed, your doctor may recommend a trabeculectomy ^[5][6].

• How it Works: The surgeon creates a new, alternative path for fluid to leave the eye, forming a small reservoir called a bleb under the eyelid ^[7].
• Success and Longevity: This has long been the “gold standard” for achieving the lowest possible pressures ^[5]. However, the success of a trabeculectomy can decline over time—in some studies, about half of younger patients required a second procedure within 10 years as the surgical site slowly healed ^[6].
• Considerations and Burdens: Because the bleb is a permanent feature, it requires lifelong monitoring for signs of infection or leak ^[7][8]. Early risks include hypotony (pressure dropping too low), bleeding, and intensive postoperative follow-up.

Glaucoma Drainage Devices (Tube Shunts)

A tube shunt (such as a valved Ahmed or non-valved Baerveldt device) is an alternative often used if a trabeculectomy has failed or isn’t suitable for your eye ^[9][10].

• How it Works: A tiny silicone tube is placed into the front of the eye to shunt fluid out to a small plate hidden under the eyelid ^[11].
• Effectiveness: In younger patients where other surgeries have failed, tube shunts can have a success rate of about 70–90% after one year ^[10][9].
• Managing Expectations: While highly effective at lowering pressure, many patients with a tube shunt will still need to use one or two eye drops to stay at their target pressure ^[10]. Risks include double vision, corneal changes, and tube exposure.

Making the Decision

There is no “one-size-fits-all” surgery for GLC1A. Your surgeon will look at several factors before making a recommendation:

1. Angle Anatomy: If gonioscopy shows that your drainage angle is wide open and healthy (other than the cellular dysfunction), an angle-based surgery like GATT may be an option ^[12][1].
2. Disease Severity: More advanced damage often requires the lower pressures typically provided by a trabeculectomy ^[13][5].
3. Prior Surgeries: If you have had eye surgery in the past, certain options may be better than others due to scar tissue ^[9][14].

The goal of any of these surgeries is not to “cure” the MYOC mutation, but to manage its effects—lowering the pressure enough to ensure your vision remains stable for the rest of your life ^[1][13].